Clinical Trials Browser

INDUSTRY × TroVax × Genitourinary × Clear all

NCT00083941 2020-10-19

A Study of TroVax Vaccine Given in Conjunction With IL-2 for Treatment of Stage IV Renal Cell Cancer

Phase 2 Completed

Carcinoma, Renal Cell

NCT00325507 2020-10-19

Safety and Biological Activity of TroVax® Vaccine Given With IL-2 in Renal Cell Carcinoma

Phase 2 Completed

Carcinoma, Renal Cell

NCT00397345 2020-10-19

TroVax Renal Immunotherapy Survival Trial

Phase 3 Completed

Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms

NCT01194960 2020-10-19

TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)

Phase 2 Terminated

Prostatic Hyperplasia, Prostatic Neoplasms